P

Inventor

PRESTRELSKI STEVEN

US16 patents
⚠️ This page may combine multiple inventors who share the name “PRESTRELSKI STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XERIS PHARMACEUTICALS INC

12 patents
US9339545B2May 17, 2016

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS INC13 citations90
US10485850B2Nov 26, 2019

Methods for producing stable therapeutic formulations in aprotic polar solvents

XERIS PHARMACEUTICALS INC8 citations83
US9649364B2May 16, 2017

Methods for producing stable therapeutic formulations in aprotic polar solvents

XERIS PHARMACEUTICALS INC12 citations83
US9138479B2Sep 22, 2015

Formulations for the treatment of diabetes

XERIS PHARMACEUTICALS INC11 citations83
US9302010B2Apr 5, 2016

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS INC5 citations82
US9314424B2Apr 19, 2016

Pastes for injection of a therapeutic agent

XERIS PHARMACEUTICALS INC3 citations70
US11590205B2Feb 28, 2023

Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

XERIS PHARMACEUTICALS INC1 citations61
US10987399B2Apr 27, 2021

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS INC0 citations60
US12514837B2Jan 6, 2026

Stable levothyroxine compositions in aprotic polar solvents

XERIS PHARMACEUTICALS INC1 citations58
US11964003B2Apr 23, 2024

Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

XERIS PHARMACEUTICALS INC1 citations52
US9295724B2Mar 29, 2016

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS INC0 citations50
US12514907B2Jan 6, 2026

Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes

XERIS PHARMACEUTICALS INC0 citations47

PRESTRELSKI STEVEN

4 patents